These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 32057528)

  • 1. Determinants of mesial temporal lobe volume loss in older individuals with preserved cognition: a longitudinal PET amyloid study.
    Montandon ML; Herrmann FR; Garibotto V; Rodriguez C; Haller S; Giannakopoulos P
    Neurobiol Aging; 2020 Mar; 87():108-114. PubMed ID: 32057528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal Volume Loss, Brain Amyloid Accumulation, and APOE Status in Cognitively Intact Elderly Subjects.
    Haller S; Montandon ML; Rodriguez C; Garibotto V; Herrmann FR; Giannakopoulos P
    Neurodegener Dis; 2019; 19(3-4):139-147. PubMed ID: 31846965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Less agreeable, better preserved? A PET amyloid and MRI study in a community-based cohort.
    Giannakopoulos P; Rodriguez C; Montandon ML; Garibotto V; Haller S; Herrmann FR
    Neurobiol Aging; 2020 May; 89():24-31. PubMed ID: 32169357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbleeds and Medial Temporal Atrophy Determine Cognitive Trajectories in Normal Aging: A Longitudinal PET-MRI Study.
    Montandon ML; Herrmann FR; Garibotto V; Rodriguez C; Haller S; Giannakopoulos P
    J Alzheimers Dis; 2020; 77(4):1431-1442. PubMed ID: 32925053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
    Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
    J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of rest-activity patterns with amyloid burden, medial temporal lobe atrophy, and cognitive impairment.
    Roh HW; Choi JG; Kim NR; Choe YS; Choi JW; Cho SM; Seo SW; Park B; Hong CH; Yoon D; Son SJ; Kim EY
    EBioMedicine; 2020 Aug; 58():102881. PubMed ID: 32736306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of Cognitive Trajectories in Normal Aging: A Longitudinal PET-MRI Study in a Community-based Cohort.
    Herrmann FR; Montandon ML; Garibotto V; Rodriguez C; Haller S; Giannakopoulos P
    Curr Alzheimer Res; 2021; 18(6):482-491. PubMed ID: 34602046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.
    Pettigrew C; Soldan A; Sloane K; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M;
    Neuroimage Clin; 2017; 16():439-446. PubMed ID: 28879085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion Tensor Imaging Predictors of Episodic Memory Decline in Healthy Elders at Genetic Risk for Alzheimer's Disease.
    Lancaster MA; Seidenberg M; Smith JC; Nielson KA; Woodard JL; Durgerian S; Rao SM
    J Int Neuropsychol Soc; 2016 Nov; 22(10):1005-1015. PubMed ID: 27903333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
    Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
    Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE ε4 associated with preserved executive function performance and maintenance of temporal and cingulate brain volumes in younger adults.
    Taylor WD; Boyd B; Turner R; McQuoid DR; Ashley-Koch A; MacFall JR; Saleh A; Potter GG
    Brain Imaging Behav; 2017 Feb; 11(1):194-204. PubMed ID: 26843007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding.
    Siddarth P; Burggren AC; Merrill DA; Ercoli LM; Mahmood Z; Barrio JR; Small GW
    PLoS One; 2018; 13(12):e0208358. PubMed ID: 30517207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.
    Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H
    J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern.
    Risacher SL; Kim S; Nho K; Foroud T; Shen L; Petersen RC; Jack CR; Beckett LA; Aisen PS; Koeppe RA; Jagust WJ; Shaw LM; Trojanowski JQ; Weiner MW; Saykin AJ;
    Alzheimers Dement; 2015 Dec; 11(12):1417-1429. PubMed ID: 25960448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.
    Blautzik J; Kotz S; Brendel M; Sauerbeck J; Vettermann F; Winter Y; Bartenstein P; Ishii K; Rominger A;
    J Alzheimers Dis; 2018; 65(3):781-791. PubMed ID: 28697560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
    Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
    Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism.
    Nielsen HM; Chen K; Lee W; Chen Y; Bauer RJ; Reiman E; Caselli R; Bu G
    Alzheimers Res Ther; 2017 Jan; 9(1):5. PubMed ID: 28137305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau pathology mediates age effects on medial temporal lobe structure.
    Wisse LE; Xie L; Das SR; de Flores R; Hansson O; Habes M; Doshi J; Davatzikos C; Yushkevich PA; Wolk DA;
    Neurobiol Aging; 2022 Jan; 109():135-144. PubMed ID: 34740075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medial temporal lobe volume is associated with neuronal loss but not with hippocampal microinfarcts despite their high frequency in aging brains.
    Montandon ML; Haller S; Scheffler M; Giannakopoulos P; Herrmann FR; Gold G; Kövari E
    Neurobiol Aging; 2020 Nov; 95():9-14. PubMed ID: 32739558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.